Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 46.03%291.06M | 37.91%235.12M | 27.12%195.63M | 81.15%927.33M | 222.71%404.64M | 41.98%199.31M | 56.77%170.49M | 11.36%153.89M | 22.09%511.91M | 4.89%125.39M |
| Cost of revenue | 52.64%202.08M | 51.90%171.62M | 18.25%131.99M | 83.37%673.47M | 305.49%317.21M | 30.44%132.39M | 40.51%112.98M | 3.70%111.62M | 15.91%367.27M | -12.48%78.23M |
| Gross profit | 32.95%88.97M | 10.41%63.5M | 50.54%63.64M | 75.51%253.86M | 85.38%87.43M | 72.10%66.92M | 102.88%57.51M | 38.35%42.28M | 41.21%144.64M | 56.40%47.16M |
| Operating expense | -36.27%8.94M | 55.29%22.62M | -3.04%18.56M | 63.61%112.86M | -13.85%17.26M | 10.31%14.03M | 10.99%14.57M | 10.09%19.14M | 26.42%68.98M | -2.40%20.04M |
| Selling and administrative expenses | -10.33%14.41M | 47.61%23.62M | -3.04%18.56M | 63.61%112.86M | -13.85%17.26M | 5.18%16.07M | 12.95%16M | 10.09%19.14M | 26.42%68.98M | 6.03%20.04M |
| -Selling and marketing expense | -53.94%2.79M | -5.42%5.14M | -39.37%3.64M | -23.40%25.16M | -10.92%7.66M | -27.18%6.06M | -16.23%5.44M | -36.39%6M | --32.85M | --8.6M |
| -General and administrative expense | 16.05%11.62M | 74.92%18.47M | 13.55%14.92M | 63.61%112.86M | -16.05%9.6M | 43.84%10.01M | 37.66%10.56M | 65.23%13.14M | 26.42%68.98M | -63.68%11.44M |
| Depreciation and amortization | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Depreciation | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Amortization | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total other operating income | 167.66%5.47M | -30.59%994K | ---- | ---- | ---- | -20.28%2.04M | 37.69%1.43M | ---- | ---- | ---- |
| Operating profit | 51.31%80.03M | -4.82%40.87M | 94.87%45.08M | 86.36%141M | 158.70%70.16M | 102.13%52.89M | 182.11%42.94M | 75.67%23.13M | 58.06%75.66M | 181.87%27.12M |
| Net non-operating interest income (expenses) | -125.98%-5.08M | -919.03%-4.91M | -346.07%-4.43M | 6.29%-4.2M | -15.46%-829K | -118.46%-2.25M | 148.00%599K | 0.10%-992K | -5.61%-4.48M | 60.38%-718K |
| Non-operating interest income | -70.86%109K | -79.30%124K | 151.09%344K | -57.70%1.07M | -81.88%383K | 146.05%374K | 256.55%599K | 37.00%137K | --2.53M | --2.11M |
| Non-operating interest expense | 97.90%5.19M | --5.03M | 322.41%4.77M | -6.29%4.2M | -57.20%1.21M | 122.02%2.62M | ---- | 3.29%1.13M | 5.61%4.48M | 1,222.97%2.83M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 0 | -15M | -2,108.40%-44.17M | -2,108.40%-44.17M | 0 | 0 | 0 | -2M | -2M |
| Less:Negative goodwill immediately recognized | --0 | --0 | --15M | 2,108.40%44.17M | 2,108.40%44.17M | --0 | --0 | --0 | --2M | --2M |
| Other non-operating income (expenses) | 120.73%2.83M | -41.67%7.65M | -73.96%1.94M | 9.28%1.28M | 81.15%13.11M | 7.43M | ||||
| Income before tax | 48.00%74.95M | -17.40%35.97M | 21.61%28.49M | 71.37%144.45M | -14.87%27.1M | 101.46%50.65M | 211.59%43.54M | 75.47%23.43M | 65.71%84.29M | 111.57%31.83M |
| Income tax | -22.82%13.37M | -7.46%10.57M | 28.76%8.36M | 151.56%43.9M | 826.31%8.34M | 136.08%17.33M | 171.59%11.42M | 23.85%6.49M | 0.12%17.45M | -123.27%-1.15M |
| Net income | 84.83%61.58M | -20.93%25.4M | 18.87%20.13M | 50.43%100.54M | -43.11%18.76M | 87.18%33.32M | 228.82%32.12M | 108.83%16.93M | 99.91%66.84M | 226.13%32.98M |
| Net income continuous operations | 84.83%61.58M | -20.93%25.4M | 18.87%20.13M | 50.43%100.54M | -43.11%18.76M | 87.18%33.32M | 228.82%32.12M | 108.83%16.93M | 99.91%66.84M | 226.13%32.98M |
| Noncontrolling interests | 15.03%4.62M | -83.76%544K | 2,753.97%5.39M | 96.32%9.92M | -42.32%2.36M | 94.76%4.02M | 817.34%3.35M | 137.50%189K | 185.20%5.05M | 247.06%4.1M |
| Net income attributable to the company | 94.40%56.96M | -13.62%24.85M | -12.00%14.74M | 46.68%90.62M | -43.22%16.4M | 86.19%29.3M | 181.08%28.77M | 94.42%16.75M | 56.95%61.78M | 91.54%28.89M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 94.40%56.96M | -13.62%24.85M | -12.00%14.74M | 46.68%90.62M | -43.22%16.4M | 86.19%29.3M | 181.08%28.77M | 94.42%16.75M | 56.23%61.78M | 89.24%28.89M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 94.37%0.1139 | -13.57%0.0497 | -11.94%0.0295 | 46.60%0.1812 | -43.25%0.0328 | 86.03%0.0586 | 180.49%0.0575 | 94.77%0.0335 | 57.05%0.1236 | 92.03%0.0578 |
| Diluted earnings per share | 94.37%0.1139 | -13.57%0.0497 | -11.94%0.0295 | 46.60%0.1812 | -43.25%0.0328 | 86.03%0.0586 | 180.49%0.0575 | 94.77%0.0335 | 57.05%0.1236 | 92.03%0.0578 |
| Dividend per share | 0 | -50.00%0.01 | 0 | 100.00%0.02 | 0 | 0 | 0.02 | 0 | 0.01 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.